We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pathophysiological Subtyping of Abnormalities in Cocaine Dependence - 9

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00015275
First Posted: April 18, 2001
Last Update Posted: January 12, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
New York MDRU
Information provided by:
National Institute on Drug Abuse (NIDA)
  Purpose
The purpose of this study is to define pathophysiological subtypes of abnormalities in subjects with cocaine dependence.

Condition Intervention Phase
Cocaine-Related Disorders Substance-Related Disorders Behavioral: Cocaine-Related Disorders Phase 4

Study Type: Interventional
Study Design: Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Pathophysiological Subtyping of Abnormalities in Cocaine Dependence

Resource links provided by NLM:


Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:
  • Identification of homogenous subgroups within total population of cocaine dependent adults

Estimated Enrollment: 0
Detailed Description:
The objective of this study is to define subgroups of patients with differential treatment outcome on the basis of differential baseline electrophysiological clusters.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Cocaine dependence. Seeking residential treatment.

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00015275


Locations
United States, New York
New York MDRU
New York, New York, United States, 10010
Sponsors and Collaborators
National Institute on Drug Abuse (NIDA)
New York MDRU
Investigators
Principal Investigator: John Rotrosen, M.D. New York MDRU
  More Information

ClinicalTrials.gov Identifier: NCT00015275     History of Changes
Other Study ID Numbers: NIDA-5-0013-9
Y01-5-0013-9
First Submitted: April 18, 2001
First Posted: April 18, 2001
Last Update Posted: January 12, 2017
Last Verified: December 2002

Additional relevant MeSH terms:
Disease
Cocaine-Related Disorders
Substance-Related Disorders
Pathologic Processes
Chemically-Induced Disorders
Mental Disorders
Cocaine
Anesthetics, Local
Anesthetics
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents
Vasoconstrictor Agents
Dopamine Uptake Inhibitors
Neurotransmitter Uptake Inhibitors
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Dopamine Agents
Neurotransmitter Agents